firesIayer96’s details
| symbol | subject | date & time | rating |
|
|
An interesting read on Wekerele and the entire Difference Capital team by Tommy Humphreys. http://ceo.ca/dcf/ |
5/17/2013 10:40:08 AM |
|
|
|
This is from the NR in January announcing the collaborative agreement with QPS: "Amorfix will also continue to provide the EP-AD assay for research use to pharmaceutical and biopharmaceutical companies on a fee for service basis." To me... |
5/16/2013 9:15:17 PM |
|
|
|
RC, Timeframe on when this will go down? |
5/16/2013 9:41:47 AM |
|
|
|
This acquisition has gotta be soon doesnt it? |
5/15/2013 9:59:32 AM |
1 |
|
|
that the closing of this next acquisition will probably be announced next week. Possibly even Monday. Remember that it was hoped to be official by May 1. We know the financing is in place. The Q1 numbers are out, they arent bogged down with that.... |
5/10/2013 12:13:56 PM |
1 |
|
|
Yes, these are impressive numbers. Revenue nearly $9.0Million, EBITDAS nearly $4.0MIllion, 44% of total revenues! Looking good going forward! |
5/9/2013 9:37:21 AM |
1 |
|
|
http://london.ctvnews.ca/new-melanoma-test-coming-to-southwestern-ontario-but-prevention-still-key-1.1273106 |
5/8/2013 11:03:58 PM |
4 |
|
|
Oct. 12, 2012 Beacon analyst Michael Mills initated coverage on E, 12-month price target of .60. I recall that this Beacon price target has since been increased to around $1.00 Feb 27, 2013 MPartners Tom Varesh initiated coverage of E with a 12-m... |
5/6/2013 5:38:36 PM |
5 |
|
|
The market seems to be sensing that the announcement of the acquisition is near, but just as near might be the Q1 results, which could take a lot of people by surprise. ast yearthe q1 results were released May 14, so assuming a similar schedule t... |
5/6/2013 3:17:35 PM |
|
|
|
Vancouver company. http://shorttandepic.com/ |
5/4/2013 4:38:38 PM |
4 |
|
No additional content to display.
Stockhouse.com: Taking
it to the street
